EDP Biotech Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

EDP Biotech General Information

Description

Operator of a medical device company intended to develop and commercialize immunodiagnostic tests. The company is developing an accurate early detection blood test which can drive the right people to confirmatory colonoscopy, providing doctors with simple and cost-effective diagnostics to improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 6701 Baum Drive
  • Suite 110
  • Knoxville, TN 37919
  • United States
+1 (865) 000-0000

EDP Biotech Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EDP Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 17-Jun-2020 0000 Completed Pre-Clinical Trials
6. Later Stage VC 00.00 Cancelled Pre-Clinical Trials
5. Later Stage VC (Series A) 27-Jun-2019 000 0000 Completed Pre-Clinical Trials
4. Later Stage VC 000.00 0000 Completed Pre-Clinical Trials
3. Angel (individual) 13-May-2013 00000 00.000 Completed Pre-Clinical Trials
2. Angel (individual) 16-Dec-2010 $2.66M $1.28M Completed Pre-Clinical Trials
1. Grant 03-Nov-2010 $244K Completed Startup
To view EDP Biotech’s complete valuation and funding history, request access »

EDP Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a medical device company intended to develop and commercialize immunodiagnostic tests. The company is develo
Diagnostic Equipment
Knoxville, TN
6 As of 2020
0000
000000000000 0000

00000 00

d minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. D
0000000000 000000000
Madison, WI
0000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EDP Biotech Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000 00000000 Formerly VC-backed Madison, WI 0000 00000 000000 - 000 00000
To view EDP Biotech’s complete competitors history, request access »

EDP Biotech Executive Team (4)

Name Title Board Seat Contact Info
Eric Mayer Chief Executive Officer
Olivia McGhee Director, Finance and Operations
Thomas Boyd Founder & Chairman
Jason Liggett Laboratory Manager
To view EDP Biotech’s complete executive team members history, request access »

EDP Biotech Board Members (6)

Name Representing Role Since
Chris Chandler Self Board Member 000 0000
Douglas Yoakley EDP Biotech Board Member 000 0000
Jeffrey Peters EDP Biotech Board Member 000 0000
Meg Retinger EDP Biotech Board Member 000 0000
Michael Spalding MD EDP Biotech Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

EDP Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EDP Biotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Company Lab Accelerator/Incubator 000 0000 000000 0
U.S. Federal Government Government Minority 000 0000 000000 0
To view EDP Biotech’s complete investors history, request access »